Welcome to this UK AstraZeneca produced and funded website
This website is intended for UK Healthcare Professionals only.
The website contains both promotional and non-promotional content.
If you are a patient or a carer of a patient prescribed an AstraZeneca product, please visit myazmed.co.uk
For any other UK residents please visit astrazeneca.co.uk
This website is intended for UK Healthcare professionals only. Other UK residents please visit astrazeneca.co.uk
Indication Statements:
The Role of STRIDE in uHCC
Dr Paul Ross from Guy's and St. Thomas' NHS Foundation Trusts and King's College Hospitals discusses the role of STRIDE in uHCC
HCC Today - Where Are We?
Dr Tim Cross from Royal Liverpool and Broadgreen University Hospital NHS Trust discusses the current treatment landscape for HCC
uHCC Case Study - An MDT Perspective
Join Dr Paul Ross, Dr Tim Cross, Dr Teik Choon See and Katharine Caddick for an MDT case study discussion
Exclusive member content
Register or Login to view
uHCC Case Study - An MDT Perspective
Join Dr Paul Ross, Dr Tim Cross, Dr Teik Choon See and Katharine Caddick for an MDT case study discussion
HIMALAYA mechanism of action video
This video details the mechanism of action of the STRIDE regimen.
Exclusive member content
Register or Login to view
HIMALAYA mechanism of action video
This video details the mechanism of action of the STRIDE regimen.
HIMALAYA hospital resource pack
This hospital resource pack covers patient initiation, dosing and administration and adverse event management for the treatment of eligible patients with advanced or unresectable hepatocellular carcinoma.
imAE guide for the STRIDE regimen in HCC
A guide to support healthcare professionals with the management of immune-mediated adverse events (imAE) of the STRIDE regimen in the HIMALAYA study.
Treatment booklet for patients with uHCC
A guide to support patients with advanced or unresectable hepatocellular carcinoma cancer undergoing treatment with IMFINZI & IMJUDO.
The diagnosis of biliary tract cancer
Understand the symptoms, risk factors, and diagnosis of biliary tract cancer.
IMFINZI imAE guide
A guide to support healthcare professionals with the management of immune-mediated adverse events (imAE) with IMFINZI.
BSG Prioritised recommendations flyer
Key recommendations from the British Society of Gastroenterology (BSG) 2023 guidelines for the diagnosis and management of cholangiocarcinoma.
The unmet need for biliary tract cancer video
Watch Prof. Shahid Khan highlight the unmet need in biliary tract cancer (BTC) within the UK.
The five pillars of imAE management video.
Watch Dr Dan Patterson discuss the five pillars of immune-mediated adverse events (imAE) management.
imAE management in aBTC guides and resources video
Watch Dr Dan Patterson discuss immune-mediated adverse event (imAE) management in advanced biliary tract cancer (aBTC) guides and resources.
Communicating imAE management with patients
Watch Dr Dan Patterson discuss communicating imAE management with patients.
BTC patient diagnosis support PDF
A patient diagnosis support PDF to help patients and healthcare professionals with the biliary tract cancer conversation.
aBTC patient treatment guide
A guide to support patients with advanced biliary tract cancer (aBTC) undergoing treatment with IMFINZI.
TOPAZ-1 national webinar series: Habilitation in patients with biliary tract cancer
Watch Prof. Brian Davidson discuss habilitation in patients with biliary tract cancer
TOPAZ-1 national webinar series: Tissue acquisition in patients with biliary tract cancer
Watch a panel of experts discuss tissue acquisition in patients with biliary tract cancer
Exclusive member content
Register or Login to view
TOPAZ-1 national webinar series: Tissue acquisition in patients with biliary tract cancer
Watch a panel of experts discuss tissue acquisition in patients with biliary tract cancer
TOPAZ-1 national webinar series: Challenges in biliary tract cancer
Watch a panel of experts discuss challenges in the management of biliary tract cancer
Exclusive member content
Register or Login to view
TOPAZ-1 national webinar series: Challenges in biliary tract cancer
Watch a panel of experts discuss challenges in the management of biliary tract cancer
TOPAZ-1 national webinar series: Patient case study
Watch Donna Hodge talk through a case study of a patient with biliary tract cancer
Exclusive member content
Register or Login to view
TOPAZ-1 national webinar series: Patient case study
Watch Donna Hodge talk through a case study of a patient with biliary tract cancer
TOPAZ-1 national webinar series: Nurse-led two-week wait pathway
Watch Donna Hodge discuss the nurse-led two-week wait pathway at the Royal Free
Biliary Tract Cancer (BTC) Care: A guide to supporting patient fitness and performance status to help optimise outcomes.
This is a guide to support Healthcare Professionals (HCPs) in optimising patient fitness with practical strategies on managing bilirubin, supporting nutrition, enhancing physical activity, and driving effective multi-disciplinary team collaboration to help deliver improved outcomes.
Real World Evidence in advanced BTC
Explore this real-world study which aimed to assess the safety and efficacy of IMFINZI + Gem-Cis in routine clinical practice.
The MATTERHORN trial for resectable GC/GOJC
A summary of the MATTERHORN trial and key data points that have informed the licensed indication
MATTERHORN hospital resource pack for treatment of eligible patients with resectable GC or GOJC.
This hospital resource pack covers patient initiation, dosing and administration and adverse event management for the treatment of eligible patients with resectable gastric cancer or gastro-oesophageal junction cancer.
GI Oncology Diet Guide/7 Day meal plan
A digital PDF 7-day meal plan created with a dietitian to help patients increase or maintain weight before cancer treatment.
ASCENT 2025 videos
Watch the videos from our inaugural ASCENT hepatobiliary summit held in June 2025 in Birmingham. Reach out to your local AstraZeneca representative if you would like to hear more about ASCENT and future meetings.
Taking care of yourself following a gastrointestinal cancer diagnosis
This is a supportive guide for healthcare professionals (HCPs) to share with their patients who have been diagnosed with gastrointestinal cancers, designed to help them feel more confident and in control of their treatment journey, with practical tips on physical activity, nutrition, and mental wellbeing before, during, and after treatment.
GB-64170 | DOP: March 2025
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to AstraZeneca by visiting https://contactazmedical.astrazeneca.com/ or by calling 0800 783 0033.
This website was created for UK HCPs and has been designed to provide information to educate, empower and enable them in the great work they are doing for patients across a range of therapy areas. This website is intended for doctors, nurses, and pharmacists in the UK. Other UK residents please visit astrazeneca.co.uk.
GB-74216| DOP : February 2026
